Your browser doesn't support javascript.
loading
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD.
Schlenk, Richard F; Weber, Daniela; Fiedler, Walter; Salih, Helmut R; Wulf, Gerald; Salwender, Hans; Schroeder, Thomas; Kindler, Thomas; Lübbert, Michael; Wolf, Dominik; Westermann, Jörg; Kraemer, Doris; Götze, Katharina S; Horst, Heinz-August; Krauter, Jürgen; Girschikofsky, Michael; Ringhoffer, Mark; Südhoff, Thomas; Held, Gerhard; Derigs, Hans-Günter; Schroers, Roland; Greil, Richard; Grießhammer, Martin; Lange, Elisabeth; Burchardt, Alexander; Martens, Uwe; Hertenstein, Bernd; Marretta, Lore; Heuser, Michael; Thol, Felicitas; Gaidzik, Verena I; Herr, Wolfgang; Krzykalla, Julia; Benner, Axel; Döhner, Konstanze; Ganser, Arnold; Paschka, Peter; Döhner, Hartmut.
Afiliação
  • Schlenk RF; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Weber D; National Center of Tumor Diseases-Trial Center, National Center of Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
  • Fiedler W; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Salih HR; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Wulf G; Department of Internal Medicine II, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Salwender H; Department of Hematology and Oncology, Eberhard-Karls University, Tübingen, Germany.
  • Schroeder T; Department of Hematology and Oncology, University Hospital of Göttingen, Göttingen, Germany.
  • Kindler T; Department of Oncology and Hematology, Asklepios Tumorzentrum, AK Altona, Hamburg, Germany.
  • Lübbert M; Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty, Duesseldorf, Germany.
  • Wolf D; Department of Hematology, Medical Oncology and Pneumology, University Medical Center, Mainz, Germany.
  • Westermann J; Department of Haematology-Oncology, Faculty of Medicine Freiburg, University of Freiburg Medical Center, Freiburg, Germany.
  • Kraemer D; Internal Medicine III, University Hospital of Bonn, Bonn, Germany.
  • Götze KS; Department of Hematology, Oncology and Tumor Immunology, Charité-Campus Virchow Clinic, Berlin, Germany.
  • Horst HA; Department of Oncology and Hematology, Hospital Oldenburg, Oldenburg, Germany.
  • Krauter J; Department of Internal Medicine III, University Hospital Klinikum rechts der Isar, Munich, Germany.
  • Girschikofsky M; Department of Internal Medicine II, University Hospital of Schleswig-Holstein, Kiel, Germany.
  • Ringhoffer M; Department of Hematology, Hemostaseology, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Südhoff T; Department of Hematology and Oncology, Hospital Elisabethinen Linz, Linz, Austria.
  • Held G; Department of Hematology and Oncology, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
  • Derigs HG; Department of Hematology and Oncology, Klinikum Passau, Passau, Germany.
  • Schroers R; Department of Internal Medicine I, University Hospital of Saarland, Homburg, Germany.
  • Greil R; Department of Internal Medicine III, Hospital Frankfurt-Hoechst, Frankfurt, Germany.
  • Grießhammer M; Department of Hematology and Oncology, Knappschaftskrankenhaus University Hospital, Bochum, Germany.
  • Lange E; IIIrd Medical Department, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute, Cancer Cluster Salzburg, Salzburg, Austria.
  • Burchardt A; Department of Hematology and Oncology, University Hospital of Minden, Germany.
  • Martens U; Departmen of Hematology and Oncology, Evangelisches Krankenhaus Hamm, Hamm, Germany.
  • Hertenstein B; Department of Hematology and Oncology, University Hospital of Gießen, Gießen, Germany.
  • Marretta L; Department of Hematology and Oncology, Klinikum am Gesundbrunnen, Heilbronn, Germany.
  • Heuser M; Department of Hematology and Oncology, Klinikum Bremen Mitte, Bremen, Germany.
  • Thol F; Department of Hematology and Oncology, Vivantes Klinikum Neukölln, Neukölln-Berlin, Germany; and.
  • Gaidzik VI; Department of Hematology, Hemostaseology, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Herr W; Department of Hematology, Hemostaseology, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Krzykalla J; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Benner A; Department of Hematology, Medical Oncology and Pneumology, University Medical Center, Mainz, Germany.
  • Döhner K; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany.
  • Ganser A; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany.
  • Paschka P; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Döhner H; Department of Hematology, Hemostaseology, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Blood ; 133(8): 840-851, 2019 02 21.
Article em En | MEDLINE | ID: mdl-30563875

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Estaurosporina / Tirosina Quinase 3 Semelhante a fms / Quimioterapia de Manutenção Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Estaurosporina / Tirosina Quinase 3 Semelhante a fms / Quimioterapia de Manutenção Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha